A Comparison of Valproate with Carbamazepine for the Treatment of Complex Partial Seizures and Secondarily Generalized Tonic–Clonic Seizures in Adults
Open Access
- 10 September 1992
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (11) , 765-771
- https://doi.org/10.1056/nejm199209103271104
Abstract
Valproate is approved for use primarily in patients with absence seizures, but the drug has a broad spectrum of activity against seizures of all types. Partial or secondarily generalized tonic—clonic seizures are often difficult to control adequately with standard treatment, usually carbamazepine or phenytoin.Keywords
This publication has 23 references indexed in Scilit:
- Valproate Monotherapy in 30 Patients with Partial SeizuresEpilepsia, 1988
- Monotherapy with Valproate in Primary Generalized EpilepsiesEpilepsia, 1987
- Valproate Monotherapy in the Management of Generalized and Partial SeizuresEpilepsia, 1987
- The comparative efficacy of antiepileptic drugs for partial and tonic-clonic seizures.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985
- Which drug for the adult epileptic patient: phenytoin or valproate?BMJ, 1985
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981
- SODIUM VALPROATE IN the TREATMENT of RESISTANT EPILEPSYActa Neurologica Scandinavica, 1976
- Sodium Valproate in Treatment of EpilepsyBMJ, 1974
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958